L-Isoleucine (BioCAD00000013064)
blood breast milk cerebrospinal fluid (csf) feces saliva sweat urine all tissues placenta prostate
Metabolite Card
Chinese Name: 异亮氨酸
Formula: C6H13NO2 (131.0946)
SMILES:
CC[C@H](C)[C@H](N)C(O)=O
Synonyms [en]
l-isoleucine; 2-Amino-3-methylvaleric acid; (2S,3S)-2-Amino-3-methylpentanoic acid; Isoleucine; ile; iso-leucine
Last reviewed on 2026-04-16.
Cite this Page
L-Isoleucine. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/L-Isoleucine
(retrieved
2026-08-20) (CAD Registry RN: BioCAD00000013064). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
Isoleucine (Ile) or L-isoleucine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (–NH2) and carboxyl (–COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-isolecuine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Isoleucine is found in all organisms ranging from bacteria to plants to animals. It is classified as a non-polar, uncharged (at physiological pH) aliphatic amino acid. Isoleucine is an essential amino acid in humans, meaning the body cannot synthesize it and that it must be obtained from the diet. In plants and microorganisms, isoleucine is synthesized starting from pyruvate and alpha-ketobutyrate. Isoleucine is classified as a branched chain amino acid (BCAA). BCAAs include three amino acids: isoleucine, leucine and valine. They are alpha amino acids whose carbon structure is marked by a beta branch point. Despite their structural similarities, BCAAs have different metabolic routes, with valine going solely to carbohydrates (glucogenic), leucine solely to fats (ketogenic) and isoleucine being both a glucogenic and a ketogenic amino acid. Isoleucine is catabolized via with alpha-ketoglutarate where upon it is oxidized and split into propionyl-CoA and acetyl-CoA. Propionyl-CoA is converted into succinyl-CoA, a TCA cycle intermediate which can be converted into oxaloacetate for gluconeogenesis (hence glucogenic). The acetyl-CoA can be fed into the TCA cycle by condensing with oxaloacetate to form citrate or used in the synthesis of ketone bodies or fatty acids. The different metabolism of BCAAs accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine are required respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. BCAAs are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia. An inability to break down isoleucine, along with other amino acids, is associated with maple syrup urine disease (MSUD) (PMID: 34125801). Isoleucine, like other BCAAs, is associated with insulin resistance. In particular, higher levels of isoleucine are observed in the blood of diabetic mice, rats, and humans (PMID 25287287). Mice fed an isoleucine deprivation diet for one day have improved insulin sensitivity, and feeding of an isoleucine deprivation diet for one week significantly decreases blood glucose levels (PMID: 24684822).
DBLinks
- CAS Registry Number: 73-32-5
- PubChem CID: 6306
- ChEBI: 17191
- HMDB: HMDB0000172
- LipidMaps: LMFA01100047
- KEGG: C00407
- BioCyc: ILE
- NCBI MeSH: Isoleucine
- Wikipedia: Isoleucine
Other DBLinks
- CAS Registry Number: 1160211-67-5
- CAS Registry Number: 131598-62-4
- CAS Registry Number: 443-79-8
- CAS Registry Number: 73-32-5
- PubChem: 3697
- PubChem: 6306
- PubChem: 791
- ChEBI: ChEBI:17191
- ChEBI: ChEBI:58045
- HMDB: HMDB0000172
- HMDB: HMDB00172
- LipidMaps: LMFA01100047
- KEGG: C00407
- KEGG: D00065
- BioCyc: ILE
- NCBI MeSH: Isoleucine
- Wikipedia: Isoleucine
- DrugBank: DB00167
- RefMet: RM0134975
- MoNA: CCMSLIB00000577889
- MoNA: CCMSLIB00000578107
- MoNA: GLS00013
- MoNA: HMDB0000172_ms_ms_271
- MoNA: HMDB0000172_ms_ms_272
- MoNA: HMDB0000172_ms_ms_273
- MoNA: KNA00041
- MoNA: KNA00042
- MoNA: KNA00043
- MoNA: KNA00320
- MoNA: KNA00321
- MoNA: KNA00322
- MoNA: KO001175
- MoNA: KO001176
- MoNA: KO001177
- MoNA: KO001178
- MoNA: KO001179
- MoNA: KO003172
- MoNA: KO003173
- MoNA: KO003174
- MoNA: KO003175
- MoNA: KO003176
- MoNA: KZ000231
- MoNA: KZ000232
- MoNA: KZ000233
- MoNA: MoNA003311
- MoNA: MoNA003312
- MoNA: MoNA003313
- MoNA: MoNA003314
- MoNA: MoNA003315
- MoNA: MoNA003316
- MoNA: MoNA010393
- MoNA: MoNA010394
- MoNA: MoNA010395
- MoNA: MoNA010396
- MoNA: MoNA010397
- MoNA: MoNA010398
- MoNA: MoNA_0006579
- MoNA: MoNA_0006580
- MoNA: MoNA_0006581
- MoNA: MoNA_0006582
- MoNA: MoNA_0007742
- MoNA: MoNA_0007743
- MoNA: MoNA_0007744
- MoNA: MoNA_0007745
- MoNA: MoNA_0007746
- MoNA: MoNA_0007747
- MoNA: MoNA_0008035
- MoNA: MoNA_0008336
- MoNA: MoNA_0008337
- MoNA: MT000039
- MoNA: OUF00312
- MoNA: OUF01004
- MoNA: PB000395
- MoNA: PB000396
- MoNA: PB000397
- MoNA: PB000398
- MoNA: PM000925
- MoNA: PR010061
- MoNA: PR030010
- MoNA: PS028001
- MoNA: PS028002
- MoNA: PS028003
- MoNA: RP000801
- MoNA: RP000802
- MoNA: RP000803
- MoNA: RP000811
- Metlin: METLIN_23
- Metlin: METLIN_45881
- PMHub: MS000000007
- metaboanalyst: 206a30e36a151ced9cff1cf2d6d4a288
- metaboanalyst: 34733ae077eb7fb214ff4eb69f6c17a3
- metaboanalyst: 52fade0e52cc55afdc7352f2b57c68aa
- metaboanalyst: 678b8599e8cdfd48c6b764c5769615a4
Class / Ontology
- WishartLab ClassyFire: [Amino acids, peptides, and analogues] Amino acids, peptides, and analogues
- RefMet: [Amino acids] Amino acids
- LipidMaps: [Amino fatty acids [FA0110]] Amino fatty acids [FA0110]
- ChEBI: [CHEBI:17191] L-isoleucine
| ID | EC Number | Name |
|---|---|---|
| KEGG:R02196 | 1.4.1.9 | L-isoleucine:NAD+ oxidoreductase(deaminating) |
| KEGG:R02197 | 1.4.3.2 | L-isoleucine:oxygen oxidoreductase (deaminating) |
| KEGG:R02199 | 2.6.1.42 | L-isoleucine:2-oxoglutarate aminotransferase |
| KEGG:R02200 | 2.6.1.32 | valine:(S)-3-methyl-2-oxopentanoate aminotransferase |
| KEGG:R03656 | 6.1.1.5 | L-isoleucine:tRNA(Ile) ligase (AMP-forming) |
| KEGG:R06726 | C06177 + 2 C00407<=>C06176 | |
| KEGG:R09344 | C18679 + C00407<=>C18680 + C00011 + C00001 | |
| KEGG:R09403 | 1.14.14.39 | L-isoleucine,[reduced NADPH---hemoprotein reductase]:oxygen oxidoreductase (N-hydroxylating) |
| KEGG:R10027 | 1.14.14.38 | L-isoleucine,[reduced NADPH---hemoprotein reductase]:oxygen oxidoreductase (N-hydroxylating) |
| KEGG:R10723 | 1.14.11.45 | L-isoleucine,2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating) |
| KEGG:R10943 | 6.3.2.47 | 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanine:L-isoleucine ligase (ADP-forming) |
| KEGG:R11078 | 5.1.1.21 | isoleucine 2-epimerase |
| KEGG:R11723 | 6.3.2.50 | L-isoleucine:acetoacetyl-CoA ligase (tenuazonic acid-forming) |
| KEGG:R12650 | 1.14.11.74 | L-isoleucine,2-oxoglutarate:oxygen oxidoreductase (31-hydroxylating) |
| BioCyc:BRANCHED-CHAINAMINOTRANSFERILEU-RXN | 2.6.1.42 | GLT + 2-KETO-3-METHYL-VALERATE --> ILE + 2-KETOGLUTARATE |
| BioCyc:ISOLEUCINE--TRNA-LIGASE-RXN | 6.1.1.5 | ILE-tRNAs + ILE + ATP --> Charged-ILE-tRNAs + PPI + AMP |
| BioCyc:TRANS-RXN-126 | L-isoleucine:Na+ symport | |
| BioCyc:TRANS-RXN-281 | L-isoleucine:proton antiport | |
| BioCyc:RXN-23889 | ILE + ATP + PROTON --> CPD-26473 + PPI | |
| BioCyc:ABC-15-RXN | 7.4.2.2 | ATP + ILE + WATER --> ADP + Pi + ILE + PROTON |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| BioCyc:TRYPANO_ILEUDEG-PWY | isoleucine degradation I |
| BioCyc:TRYPANO_PWY-3001 | isoleucine biosynthesis I |
| BioCyc:TRYPANO_ILEUSYN-PWY | isoleucine biosynthesis I (from threonine) |
| BioCyc:TRYPANO_THREOCAT-PWY | superpathway of threonine metabolism |
| PathBank:SMP0000820 | tRNA Charging |
| PathBank:SMP0000824 | tRNA Charging 2 |
| PathBank:SMP0000838 | Isoleucine Biosynthesis |
| WikiPathways:WP3604 | Biochemical pathways: part I |
| WikiPathways:WP3953 | mRNA, protein, and metabolite inducation pathway by cyclosporin A |
| WikiPathways:WP3622 | AtMetExpress overview |
| WikiPathways:WP4599 | Glucosinolate biosynthesis from branched-chain amino acid |
| WikiPathways:WP4686 | Leucine, isoleucine and valine metabolism |
| WikiPathways:WP662 | Amino acid metabolism |
| WikiPathways:WP661 | Glucose homeostasis |
| WikiPathways:WP1451 | Valine, leucine and isoleucine degradation |
| WikiPathways:WP3925 | Amino acid metabolism |
| PathBank:SMP0120662 | 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I |
| PathBank:SMP0120806 | 3-Hydroxyisobutyric Aciduria |
| PathBank:SMP0120440 | 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency |
| PathBank:SMP0120444 | 3-Methylglutaconic Aciduria Type IV |